Online citations, reference lists, and bibliographies.
← Back to Search

Longitudinal Perceptions Of Prognosis And Goals Of Therapy In Patients With Metastatic Non-small-cell Lung Cancer: Results Of A Randomized Study Of Early Palliative Care.

J. Temel, J. Greer, S. Admane, E. Gallagher, V. Jackson, T. Lynch, I. Lennes, C. Dahlin, W. Pirl
Published 2011 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
PURPOSE Understanding of prognosis among terminally ill patients impacts medical decision making. The aims of this study were to explore perceptions of prognosis and goals of therapy in patients with metastatic non-small-cell lung cancer (NSCLC) and to examine the effect of early palliative care on these views over time. PATIENTS AND METHODS Patients with newly diagnosed metastatic NSCLC were randomly assigned to receive either early palliative care integrated with standard oncology care or standard oncology care alone. Participants completed baseline and longitudinal assessments of their perceptions of prognosis and the goals of cancer therapy over a 6-month period. RESULTS We enrolled 151 participants on the study. Despite having terminal cancer, one third of patients (46 of 145 patients) reported that their cancer was curable at baseline, and a majority (86 of 124 patients) endorsed getting rid of all of the cancer as a goal of therapy. Baseline perceptions of prognosis (ie, curability) and goals of therapy did not differ significantly between study arms. A greater percentage of patients assigned to early palliative care retained or developed an accurate assessment of their prognosis over time (82.5% v 59.6%; P = .02) compared with those receiving standard care. Patients receiving early palliative care who reported an accurate perception of their prognosis were less likely to receive intravenous chemotherapy near the end of life (9.4% v 50%; P = .02). CONCLUSION Many patients with newly diagnosed metastatic NSCLC hold inaccurate perceptions of their prognoses. Early palliative care significantly improves patient understanding of prognosis over time, which may impact decision making about care near the end of life.
This paper references
10.1200/JCO.2001.19.18.3884
Quality of life in palliative cancer care: results from a cluster randomized trial.
M. Jordhøy (2001)
10.1089/109662101750290191
Symptom frequency and severity in patients with metastatic or locally recurrent lung cancer: a prospective study using the Lung Cancer Symptom Scale in a community hospital.
S. Lutz (2001)
10.1007/s00520-003-0501-5
Family caregiver knowledge of treatment intent in a longitudinal study of patients with advanced cancer
C. Burns (2003)
10.1200/JCO.2005.11.138
Communicating with realism and hope: incurable cancer patients' views on the disclosure of prognosis.
R. Hagerty (2005)
10.3816/CLC.2006.N.001
Comprehensive symptom management in patients with advanced-stage non-small-cell lung cancer.
J. Temel (2006)
10.1200/JCO.2004.06.050
Perspectives, preferences, care practices, and outcomes among older and middle-aged patients with late-stage cancer.
J. Rose (2004)
10.1056/NEJMOA061884
Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer.
A. Sandler (2006)
10.1200/JCO.2006.05.8073
Symptom improvement in lung cancer patients treated with erlotinib: quality of life analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21.
A. Bezjak (2006)
10.1200/JCO.2004.08.163
Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy.
N. Hanna (2004)
10.1001/jama.2009.1198
Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the Project ENABLE II randomized controlled trial.
Marie Bakitas (2009)
10.1200/JCO.2008.17.7568
Phase II study of an outpatient palliative care intervention in patients with metastatic cancer.
M. Follwell (2009)
10.1001/archinternmed.2008.587
Health care costs in the last week of life: associations with end-of-life conversations.
B. Zhang (2009)
10.1038/bjc.1995.124
Symptoms at presentation for treatment in patients with lung cancer: implications for the evaluation of palliative treatment. The Medical Research Council (MRC) Lung Cancer Working Party.
P. Hopwood (1995)
10.1016/J.JPAINSYMMAN.2004.03.002
Simultaneous care: a model approach to the perceived conflict between investigational therapy and palliative care.
F. Meyers (2004)
10.1001/JAMA.279.21.1709
Relationship between cancer patients' predictions of prognosis and their treatment preferences.
J. Weeks (1998)
10.1200/JCO.2006.06.5326
Communication about prognosis between parents and physicians of children with cancer: parent preferences and the impact of prognostic information.
J. Mack (2006)
10.1200/JCO.2007.15.0375
Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer.
G. Scagliotti (2008)
10.1200/JCO.2006.06.007
Discussing prognosis: "how much do you want to know?" talking to patients who are prepared for explicit information.
A. Back (2006)
10.1200/JCO.2009.26.8870
Cancer patients' roles in treatment decisions: do characteristics of the decision influence roles?
N. Keating (2010)
10.1200/JCO.2009.22.9799
Prognostic acceptance and the well-being of patients receiving palliative care for cancer.
G. Thompson (2009)
10.1001/JAMA.290.16.2149
Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial.
M. Kris (2003)
10.1056/NEJMOA011954
Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer.
J. Schiller (2002)
10.1200/JCO.20.2.503
When the treatment goal is not cure: are cancer patients equipped to make informed decisions?
M. Gattellari (2002)
10.1056/NEJMoa1000678
Early palliative care for patients with metastatic non-small-cell lung cancer.
J. Temel (2010)
10.1200/JCO.2006.09.2627
Phase II study: integrated palliative care in newly diagnosed advanced non-small-cell lung cancer patients.
J. Temel (2007)
10.1001/JAMA.284.19.2476
Factors considered important at the end of life by patients, family, physicians, and other care providers.
K. Steinhauser (2000)
10.1200/JCO.2006.08.3170
Understanding of prognosis among parents of children with cancer: parental optimism and the parent-physician interaction.
J. Mack (2007)
10.1200/JCO.1997.15.1.330
Trading treatment toxicity for survival in locally advanced non-small cell lung cancer.
M. Brundage (1997)
10.1001/ARCHINTE.164.1.83
The comprehensive care team: a controlled trial of outpatient palliative medicine consultation.
M. Rabow (2004)
10.1200/JCO.2007.12.6110
Hope and prognostic disclosure.
J. Mack (2007)
10.1200/jco.2009.27.15_suppl.e20635
Components of early intervention outpatient palliative care consultation in patients with incurable NSCLC.
V. Jackson (2009)
10.1016/S0885-3924(01)00334-7
Preparing for the end of life: preferences of patients, families, physicians, and other care providers.
K. Steinhauser (2001)
10.1016/S0140-6736(09)60569-9
Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial
R. Pirker (2009)
10.7326/0003-4819-132-10-200005160-00011
In Search of a Good Death: Observations of Patients, Families, and Providers
K. Steinhauser (2000)
10.1016/S0885-3924(02)00599-7
Is there evidence that palliative care teams alter end-of-life experiences of patients and their caregivers?
I. Higginson (2003)
10.1136/bmj.317.7161.771
Preferences for chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviews
G. Silvestri (1998)
10.1002/pon.1450
Patient willingness to undergo chemotherapy and thoracic radiotherapy for locally advanced non‐small cell lung cancer
T. Hirose (2009)
10.1038/sj.bjc.6604395
Enhancing treatment decision-making: pilot study of a treatment decision aid in stage IV non-small cell lung cancer
N. Leighl (2008)
10.1001/JAMA.284.19.2469
Understanding of prognosis among parents of children who died of cancer: impact on treatment goals and integration of palliative care.
J. Wolfe (2000)
10.1111/J.1365-2354.2005.00601.X
Knowledge of treatment intent among patients with advanced cancer: a longitudinal study.
P. Craft (2005)
10.1056/NEJMSA012528
Understanding the treatment preferences of seriously ill patients.
T. Fried (2002)



This paper is referenced by
10.1016/j.mayocp.2019.01.013
Non-Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment.
N. Duma (2019)
10.1007/s00520-013-2080-4
Physical exercise and therapy in terminally ill cancer patients: a retrospective feasibility analysis
W. Jensen (2013)
10.1200/JCO.2016.68.5651
Promoting End-of-Life Discussions in Advanced Cancer: Effects of Patient Coaching and Question Prompt Lists.
R. Rodenbach (2017)
10.1177/1049909118824542
Korean Physicians’ Perspectives on Prognostication in Palliative Care: A Qualitative Study
E. Lee (2019)
10.1200/JCO.2012.45.7473
Patient preference and contraindications in measuring quality of care: what do administrative data miss?
J. Ryoo (2013)
10.1200/JCO.2013.54.6614
Providing high-quality and affordable intensive care to patients with cancer: The forgotten brick in the steep wall of costs throughout the cancer care continuum.
M. Soares (2014)
10.1200/JOP.18.00346
1-2-3 Project: A Quality Improvement Initiative to Normalize and Systematize Palliative Care for All Patients With Cancer in the Outpatient Clinic Setting.
Anjali V. Desai (2018)
10.1159/000495699
Early Integration of Palliative and Oncological Care: Con
Ulrich S. Schuler (2018)
10.1080/10428194.2018.1564047
Patterns of end-of-life hospital care for patients with non-Hodgkin lymphoma: exploring the landscape
J. Philip (2019)
10.1007/s00761-019-0601-6
Der onkologische Patient im Spannungsfeld zwischen wissenschaftlichem Standard und praktischer Individualisierung in der Onkologie
H. Matthes (2019)
10.1002/14651858.CD012780.pub2
The effectiveness and cost-effectiveness of hospital-based specialist palliative care for adults with advanced illness and their caregivers.
S. Bajwah (2020)
10.1016/J.ACURO.2016.03.008
Supervivencia del cáncer de próstata avanzado en España según escala de Gleason, edad y estadio
J. Campa (2016)
10.21294/1814-4861-2018-17-5-72-76
ARRANGEMENT OF WORK AT PALLIATIVE CARE DEPARTMENT IN ALMETYEVSK BRANCH OF THE REPUBLICAN CLINICAL ONCOLOGICAL DISPENSARY OF THE MINISTRY OF HEALTH OF TATARSTAN REPUBLIC
F. Akhmetzyanov (2018)
10.1177/1049909120907601
The Life Experiences Among Primary Family Caregivers of Home-Based Palliative Care
Meng-Ping Wu (2020)
10.1007/s13187-015-0827-y
Factors Influencing Chemotherapy Goal Perception in Newly Diagnosed Cancer Patients
O. Gumusay (2015)
10.1515/spircare-2016-0171
Gespräch über Leben und Sterben mit Schwester Monika Düllmann im Französischen Hospital Jerusalem
Eckhard Frick (2016)
10.1016/S1877-1203(16)30038-6
Comment intégrer de manière précoce les soins palliatifs pour les patients atteints de cancer bronchique
C. Bouleuc (2015)
10.1136/thoraxjnl-2018-212967
Palliative care in mesothelioma: Are current services RESPECT-able enough?
N. Kumar (2019)
10.1097/CPM.0000000000000203
Providing Palliative Care for Patients With Lung Cancer
B. Bade (2017)
10.1007/s00740-016-0093-6
Frühzeitige spezialisierte palliativmedizinische Mitbehandlung
J. Gaertner (2016)
10.1007/s00761-020-00812-8
„Gesagt ist nicht gehört, gehört ist nicht verstanden“ – Therapiezieleinschätzung aus Sicht von PatientInnen in der Radiologie
Teresa Zetzl (2020)
10.1002/jso.25499
Timing of palliative care: When to call for a palliative care consult
C. J. R. Schlick (2019)
10.1891/9780826127198.0001
Palliative Care Nursing
A. Wilkinson (2018)
10.1007/s40141-017-0150-0
The Intersection of Oncology Prognosis and Cancer Rehabilitation
S. Smith (2017)
10.1007/978-3-319-26387-8_2
Quality Measures for Oncologic Emergency Medicine
Tracy E. Spinks (2016)
10.1200/JOP.2016.014605
Preparing for Value-Based Payment: A Stepwise Approach for Cancer Centers.
K. Adelson (2016)
10.4103/0973-1075.185028
Integration of Early Specialist Palliative Care in Cancer Care and Patient Related Outcomes: A Critical Review of Evidence
N. Salins (2016)
An ethnographic study of palliative care in a Nigerian hospital
D. Agom (2019)
10.1007/s00520-015-2624-x
Statin use in cancer patients with brain metastases: a missed communication opportunity at the end of life
Jacqueline A. Mullvain (2015)
10.1002/cncr.33259
Patient and caregiver agreement on prognosis estimates for older adults with advanced cancer.
Kah Poh Loh (2020)
10.1159/000496407
Communication along Milestones in Lung Cancer Patients with Advanced Disease
M. Villalobos (2019)
10.1200/JCO.2013.51.0651
Delivering high-quality and affordable care throughout the cancer care continuum.
Y. Shih (2013)
See more
Semantic Scholar Logo Some data provided by SemanticScholar